166 related articles for article (PubMed ID: 27678549)
1. Neurobehavioral effects of vigabatrin and its ability to induce DNA damage in brain cells after acute treatment in rats.
Sousa K; Decker N; Pires TR; Papke DK; Coelho VR; Pflüger P; Pereira P; Picada JN
Psychopharmacology (Berl); 2017 Jan; 234(1):129-136. PubMed ID: 27678549
[TBL] [Abstract][Full Text] [Related]
2. Genotoxic and mutagenic effects of vigabatrin, a γ-aminobutyric acid transaminase inhibitor, in Wistar rats submitted to rotarod task.
Coelho VR; Sousa K; Pires TR; Papke D; Vieira CG; de Souza LP; Leal MB; Schunck R; Picada JN; Pereira P
Hum Exp Toxicol; 2016 Sep; 35(9):958-65. PubMed ID: 26500220
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis.
Luszczki JJ; Wojcik-Cwikla J; Andres MM; Czuczwar SJ
Neuropsychopharmacology; 2005 May; 30(5):958-73. PubMed ID: 15525996
[TBL] [Abstract][Full Text] [Related]
4. Long-term vigabatrin treatment modifies pentylenetetrazole-induced seizures in mice: focused on GABA brain concentration.
Świąder MJ; Świąder K; Zakrocka I; Krzyżanowski M; Wróbel A; Łuszczki JJ; Czuczwar SJ
Pharmacol Rep; 2020 Apr; 72(2):322-330. PubMed ID: 32048251
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic analyses of vigabatrin (VGB)-treated mice: GABA-transaminase inhibition significantly alters amino acid profiles in murine neural and non-neural tissues.
Walters DC; Arning E; Bottiglieri T; Jansen EEW; Salomons GS; Brown MN; Schmidt MA; Ainslie GR; Roullet JB; Gibson KM
Neurochem Int; 2019 May; 125():151-162. PubMed ID: 30822440
[TBL] [Abstract][Full Text] [Related]
6. Maternal exposure to the antiepileptic drug vigabatrin affects postnatal development in the rat.
Lombardo SA; Leanza G; Meli C; Lombardo ME; Mazzone L; Vincenti I; Cioni M
Neurol Sci; 2005 Jun; 26(2):89-94. PubMed ID: 15995825
[TBL] [Abstract][Full Text] [Related]
7. Time course of the GABAergic effects of vigabatrin: is the time course of brain GABA related to platelet GABA-transaminase inhibition?
Valdizán EM; García AP; Armijo JA
Epilepsia; 1999 Aug; 40(8):1062-9. PubMed ID: 10448817
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term vigabatrin administration on the immature rat brain.
Qiao M; Malisza KL; Del Bigio MR; Kozlowski P; Seshia SS; Tuor UI
Epilepsia; 2000 Jun; 41(6):655-65. PubMed ID: 10840396
[TBL] [Abstract][Full Text] [Related]
9. Vigabatrin in low doses selectively suppresses the clonic component of audiogenically kindled seizures in rats.
Vinogradova LV; Kuznetsova GD; Shatskova AB; van Rijn CM
Epilepsia; 2005 Jun; 46(6):800-10. PubMed ID: 15946321
[TBL] [Abstract][Full Text] [Related]
10. Chronic elevation of brain GABA levels beginning two days after status epilepticus does not prevent epileptogenesis in rats.
Halonen T; Nissinen J; Pitkänen A
Neuropharmacology; 2001 Mar; 40(4):536-50. PubMed ID: 11249963
[TBL] [Abstract][Full Text] [Related]
11. Effect of the GABA-transaminase inhibitor vigabatrin on exploratory behaviour in socially isolated rats.
Sherif F; Oreland L
Behav Brain Res; 1995 Dec; 72(1-2):135-40. PubMed ID: 8788866
[TBL] [Abstract][Full Text] [Related]
12. Vigabatrin-Induced Retinal Functional Alterations and Second-Order Neuron Plasticity in C57BL/6J Mice.
Chan K; Hoon M; Pattnaik BR; Ver Hoeve JN; Wahlgren B; Gloe S; Williams J; Wetherbee B; Kiland JA; Vogel KR; Jansen E; Salomons G; Walters D; Roullet JB; Gibson KM; McLellan GJ
Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):17. PubMed ID: 32053727
[TBL] [Abstract][Full Text] [Related]
13. Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRS.
Verhoeff NP; Petroff OA; Hyder F; Zoghbi SS; Fujita M; Rajeevan N; Rothman DL; Seibyl JP; Mattson RH; Innis RB
Epilepsia; 1999 Oct; 40(10):1433-8. PubMed ID: 10528940
[TBL] [Abstract][Full Text] [Related]
14. Beneficial interaction between vigabatrin and valproate against seizures induced by pentylenetetrazole in mice.
Cuadrado A; Armijo JA
Pharmacol Res; 2005 May; 51(5):489-96. PubMed ID: 15749465
[TBL] [Abstract][Full Text] [Related]
15. Vigabatrin protects against kainic acid-induced neuronal damage in the rat hippocampus.
Halonen T; Miettinen R; Toppinen A; Tuunanen J; Kotti T; Riekkinen PJ
Neurosci Lett; 1995 Jul; 195(1):13-6. PubMed ID: 7478243
[TBL] [Abstract][Full Text] [Related]
16. DNA damage in brain cells and behavioral deficits in mice after treatment with high doses of amantadine.
Kaefer V; Semedo JG; Silva Kahl VF; Von Borowsky RG; Gianesini J; Ledur Kist TB; Pereira P; Picada JN
J Appl Toxicol; 2010 Nov; 30(8):745-53. PubMed ID: 20575081
[TBL] [Abstract][Full Text] [Related]
17. The Ameliorative Effect of Empagliflozin in Vigabatrin-Induced Cerebellar/Neurobehavioral Deficits: Targeting mTOR/AMPK/SIRT-1 Signaling Pathways.
Amer RM; Eltokhy AK; Elesawy RO; Barakat AN; Basha E; Eldeeb OS; Aboalsoud A; Elgharabawy NM; Ismail R
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744783
[No Abstract] [Full Text] [Related]
18. Neurobehavioral and genotoxic aspects of rosmarinic acid.
Pereira P; Tysca D; Oliveira P; da Silva Brum LF; Picada JN; Ardenghi P
Pharmacol Res; 2005 Sep; 52(3):199-203. PubMed ID: 16026713
[TBL] [Abstract][Full Text] [Related]
19. Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use-limiting visual field defects.
Walters DC; Jansen EEW; Ainslie GR; Salomons GS; Brown MN; Schmidt MA; Roullet JB; Gibson KM
Pharmacol Res Perspect; 2019 Feb; 7(1):e00456. PubMed ID: 30631446
[TBL] [Abstract][Full Text] [Related]
20. [Monotherapy with vigabatrin in the treatment of West's syndrome].
Rufo M; Santiago C; Castro E; Ocaña O
Rev Neurol; 1997 Sep; 25(145):1365-8. PubMed ID: 9377291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
